Normal view MARC view ISBD view

Prognostic variability among chronic pain patients: implications for study design, interpretation, and reporting. [electronic resource]

By:

Deyo, R A

Contributor(s):

Producer: 19880412Description: 174-8 p. digitalISSN:

0003-9993

Subject(s):

In: Archives of physical medicine and rehabilitation vol. 69

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

to post a comment.

Back to results

1 Update on the mechanism of action of bimatoprost: a review and discussion of new evidence.
by Krauss, Achim H-P
2 Bimatoprost effects on aqueous humor dynamics in monkeys.
by Woodward, David F
3 Unique response profile of trabecular meshwork cells to the novel selective glucocorticoid receptor agonist, GW870086X.
by Stamer, W Daniel
4 Morphological changes in the anterior eye segment after long-term treatment with different receptor selective prostaglandin agonists and a prostamide.
by Richter, Markus
5 Sjögren's syndrome associated dry eye in a mouse model is ameliorated by topical application of integrin α4 antagonist GW559090.
by Contreras-Ruiz, Laura
6 Intraocular Pressure-Lowering Activity of NCX 470, a Novel Nitric Oxide-Donating Bimatoprost in Preclinical Models.
by Impagnatiello, Francesco
7 Antiglaucoma EP
by Woodward, David F
8 Comparison of prostaglandin F2alpha, bimatoprost (prostamide), and butaprost (EP2 agonist) on Cyr61 and connective tissue growth factor gene expression.
by Liang, Yanbin
9 Prostanoid EP4 receptor stimulation produces ocular hypotension by a mechanism that does not appear to involve uveoscleral outflow.
by Woodward, David F
10 Improvement of Outcome Measures of Dry Eye by a Novel Integrin Antagonist in the Murine Desiccating Stress Model.
by Krauss, Achim H
11 Ocular hypotensive activity of prostaglandin F2 alpha (PGF2 alpha) analogs with neutral substituents at position 1 is predicted by the isolated cat iris sphincter smooth muscle preparation but not Ca+ signalling in Swiss 3T3 cells.
by Burk, Robert M
12 Topical pazopanib blocks VEGF-induced vascular leakage and neovascularization in the mouse retina but is ineffective in the rabbit.
by Iwase, Takeshi
13 The prostanoid EP2 receptor agonist butaprost increases uveoscleral outflow in the cynomolgus monkey.
by Nilsson, Siv F E
14 Bimatoprost and prostaglandin F(2 alpha) selectively stimulate intracellular calcium signaling in different cat iris sphincter cells.
by Spada, Clayton S
15 Ocular hypotensive activity of BOL-303259-X, a nitric oxide donating prostaglandin F2α agonist, in preclinical models.
by Krauss, Achim H P
16 Novel CCR3 Antagonists Are Effective Mono- and Combination Inhibitors of Choroidal Neovascular Growth and Vascular Permeability.
by Nagai, Nori
17 A novel nitric oxide releasing prostaglandin analog, NCX 125, reduces intraocular pressure in rabbit, dog, and primate models of glaucoma.
by Borghi, Valentina